Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market by Type (Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL, Rolapitant), By Application (Acute CINV, Delayed CINV) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market by Type (Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL, Rolapitant), By Application (Acute CINV, Delayed CINV) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130112 3300 Pharma & Healthcare 377 233 Pages 4.8 (41)
                                          

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030. The market is driven by factors such as increasing incidence of cancer, rising awareness about CINV drugs, and technological advancements in the field of oncology. The global chemotherapy induced nausea and vomiting (CINV) drugs market is segmented on the basis of type into aloxi, zofran generic, kytril generic, emend, akynzeo, sustol and rolapitant; application into acute CINV and delayed CINV; region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA). -The global CINV drugs market is expected to grow at a CAGR of 4.5% from 2017 to 2022. -The US is the largest market for CINV drugs, accounting for over 50% of the total revenue in 2016. -CINV drugs are available as oral tablets, capsules, or liquids that can be taken with or without food.

Industry Growth Insights published a new data on “Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market”. The research report is titled “Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market research by Types (Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL, Rolapitant), By Applications (Acute CINV, Delayed CINV), By Players/Companies GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck, Tesaro”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Research Report

By Type

Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL, Rolapitant

By Application

Acute CINV, Delayed CINV

By Companies

GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck, Tesaro

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Outlook


Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report Segments:

The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is segmented on the basis of:

Types

Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL, Rolapitant

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Acute CINV, Delayed CINV

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GlaxoSmithKline
  2. Helsinn
  3. Heron Therapeutics
  4. Merck
  5. Tesaro

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Overview


Highlights of The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Aloxi
    2. Zofran Generic
    3. Kytril Generic
    4. Emend
    5. Akynzeo
    6. SUSTOL
    7. Rolapitant
  1. By Application:

    1. Acute CINV
    2. Delayed CINV
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Chemotherapy induced nausea and vomiting (CINV) drugs are medications that can help to prevent or reduce the symptoms of chemotherapy-induced nausea and vomiting. CINV drugs may be prescribed by a doctor in combination with other treatments for cancer, such as radiation therapy or surgery.

Some of the key players operating in the chemotherapy induced nausea and vomiting (cinv) drugs market are GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck, Tesaro.

The chemotherapy induced nausea and vomiting (cinv) drugs market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market - Supply Chain
   4.5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Forecast
      4.5.1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Absolute $ Opportunity

5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
      5.3.1. Aloxi
      5.3.2. Zofran Generic
      5.3.3. Kytril Generic
      5.3.4. Emend
      5.3.5. Akynzeo
      5.3.6. SUSTOL
      5.3.7. Rolapitant
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
      6.3.1. Acute CINV
      6.3.2. Delayed CINV
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share Forecast, 2019-2029

9. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
      9.4.1. Acute CINV
      9.4.2. Delayed CINV
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
      9.7.1. Aloxi
      9.7.2. Zofran Generic
      9.7.3. Kytril Generic
      9.7.4. Emend
      9.7.5. Akynzeo
      9.7.6. SUSTOL
      9.7.7. Rolapitant
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share Forecast, 2019-2029

10. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
      10.4.1. Acute CINV
      10.4.2. Delayed CINV
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
      10.7.1. Aloxi
      10.7.2. Zofran Generic
      10.7.3. Kytril Generic
      10.7.4. Emend
      10.7.5. Akynzeo
      10.7.6. SUSTOL
      10.7.7. Rolapitant
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share Forecast, 2019-2029

11. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
      11.4.1. Acute CINV
      11.4.2. Delayed CINV
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Chemotherpy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
      11.7.1. Aloxi
      11.7.2. Zofran Generic
      11.7.3. Kytril Generic
      11.7.4. Emend
      11.7.5. Akynzeo
      11.7.6. SUSTOL
      11.7.7. Rolapitant
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share, 2019-2029

12. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
      12.4.1. Acute CINV
      12.4.2. Delayed CINV
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
      12.7.1. Aloxi
      12.7.2. Zofran Generic
      12.7.3. Kytril Generic
      12.7.4. Emend
      12.7.5. Akynzeo
      12.7.6. SUSTOL
      12.7.7. Rolapitant
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share, 2019-2029

13. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
      13.4.1. Acute CINV
      13.4.2. Delayed CINV
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
      13.7.1. Aloxi
      13.7.2. Zofran Generic
      13.7.3. Kytril Generic
      13.7.4. Emend
      13.7.5. Akynzeo
      13.7.6. SUSTOL
      13.7.7. Rolapitant
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Market Share Analysis
   14.2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors and Customers
   14.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GlaxoSmithKline
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Helsinn
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Heron Therapeutics
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Merck
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Tesaro
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. COMPANY6
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
 &nbs

Our Trusted Clients

Contact Us